Takashi Watanabe

发表

Maternal T and B cell engraftment in two cases of X-linked severe combined immunodeficiency with IgG1 gammopathy.

H. Kanegane, T. Morio, M. Takagi, 2017, Clinical immunology.

NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome

E. Newell, H. Ikeda, T. Sasada, 2022, Journal for ImmunoTherapy of Cancer.

Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy

Y. Kodera, Y. Doki, M. Murakami, 2022, Cancer Immunology, Immunotherapy.

Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial

H. Ikeda, K. Horibe, A. Matsumine, 2022, BMJ Open.

Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment

Takashi Watanabe, 2021, Cancers.

Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor

G. Suzuki, A. Yamaura, Takashi Watanabe, 2004, Journal of Neuro-Oncology.

A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma

A. Matsumine, T. Sasada, H. Shiku, 2023, International journal of cancer.

A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumour responses in synovial sarcoma patients

H. Ikeda, T. Sasada, E. Sato, 2019, Annals of Oncology.

Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.

A. Hirao, Takashi Watanabe, Y. Kawano, 1993, Blood.